European consensus table on the use of botulinum toxin type A in adult spasticity. - Wikidata - awgldk - TriplyDB

European consensus table on the use of botulinum toxin type A in adult spasticity.

European consensus table on the use of botulinum toxin type A in adult spasticity.

http://www.wikidata.org/entity/Q34604258

about

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity Symptomatic management in multiple sclerosis Botulinum Neurotoxin Type A in Neurology: Update Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.Early development of spasticity following stroke: a prospective, observational trial Effect of ultrasonography-guided botulinum toxin type a injection in holmes' tremor secondary to pontine hemorrhage: case report.Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment.Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin.Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Neurorehabilitation of stroke.Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.Enhancing patient-provider communication for long-term post-stroke spasticity management.The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Botulinum toxin for neuropathic pain and spasticity: an overview.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Therapeutic use of botulinum toxin in neurorehabilitation.An international survey of patients living with spasticity.Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.Pharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity.Goals Set by Patients Using the ICF Model before Receiving Botulinum Injections and Their Relation to Spasticity Distribution.Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.Quality of life and costs of spasticity treatment in German stroke patients.Physical therapy for an adult with chronic stroke after botulinum toxin injection for spasticity: a case report.Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait Evaluation of clinical outcomes of patients with post-stroke wrist and finger spasticity after ultrasonography-guided BTX-A injection and rehabilitation training.A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.

P2860

Q26750450-EE31F91F-72B5-436A-A717-2F0145C8FA09 Q26766544-97BAE68C-5A0E-4080-A88F-F9FDBD797A6B Q26779897-A90EBEE1-B672-4FD5-9827-68BF36B82C7F Q26781047-66E4EB82-2130-474A-9180-FDC05F0AD072 Q26798457-5A0BE43E-0FEF-488D-BBDE-641633CC5A39 Q28074221-07D940AB-E23A-429E-A582-C23B5D3259F4 Q28088625-93A6E646-D08D-4040-9A6C-18D122F1A3A2 Q30730044-EB06A607-CF06-464B-98DB-972096E06EDF Q33723150-ECFAE970-279E-465F-967D-E396150DFF56 Q33942879-C5ED509F-BCB7-44CC-8E90-818352CC3591 Q34458191-876B129B-1A50-40D5-B688-4EAA9A670D60 Q35564045-0F1EAC35-83C4-46D2-A6AC-55C6A9868EBC Q36209475-955545AB-342A-4DC7-8976-8E5C2E46C70D Q36456943-3C06FF5B-A682-40DD-8285-D98D61620582 Q36864584-BCBFC71F-4831-42AC-AAF7-59B7F9681724 Q37340491-AA81892D-3C0F-4FCD-A454-D573F54BB0EA Q37632889-7DFE3E12-8E42-4C4F-8C07-F403E13A7937 Q37737039-5B03D3E4-C162-468B-936F-693C06694B7A Q37801960-F8B9E2D4-42BF-4E40-B158-A2FAB5C7564F Q37888668-0C93D551-C2EC-43A4-9FD8-5F41466C9A24 Q37941490-F6863B75-F61D-4ADC-A2A2-FFCD461E5242 Q37995787-0BA24BE0-F41F-41D0-84F5-DCCA53FC2BEF Q38099673-0A007367-B321-4954-AEE2-C67B6224E009 Q38122349-52B32139-0B78-4FA2-90ED-85D8017F4286 Q38196928-9BEE4E3F-9011-4D06-A82D-5EB083A22CBD Q38263487-70AB4FB7-22A2-4CA1-B2CE-08D9AA20A025 Q38414925-789450B5-EF1A-447B-B093-9E1F8D897077 Q38559645-5F087640-005C-45AC-9049-E43BC32ADF08 Q38704938-E3E2DF81-17A0-4E64-AA75-617014BE4380 Q38735879-72AC7DE8-A2FE-43D8-BB3E-21AD66245764 Q39327282-564DF43C-E4E9-42CE-B131-9BBCAC5ADB6C Q39446871-93D6AD84-E6B5-48D1-8F5B-591336B8CA7F Q39619656-7DD3A939-4752-46A4-95FE-C75BB189C19A Q39792583-B83E84C4-F217-4C7D-8597-127376DE1C0A Q41456082-DD99EA91-4E86-4212-96CD-C283D1CE12FB Q42580667-ADAF51BC-0B01-47EB-A46E-8E693C91D2CA Q42635046-3CC7F24E-89F5-4563-9E8E-9CE57D6C3626 Q44502462-340458AA-D81F-4904-922B-61D377E0D8D0 Q44902919-04D3715A-C929-4925-9F0D-88F2390A328F Q45945324-D3C88518-AA22-4513-9B7C-3DB7B0F22FEE

P2860

European consensus table on the use of botulinum toxin type A in adult spasticity.

http://www.wikidata.org/entity/Q34604258

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

European consensus table on the use of botulinum toxin type A in adult spasticity.

@ast

European consensus table on the use of botulinum toxin type A in adult spasticity.

@en

European consensus table on the use of botulinum toxin type A in adult spasticity.

@nl

type

label

European consensus table on the use of botulinum toxin type A in adult spasticity.

@ast

European consensus table on the use of botulinum toxin type A in adult spasticity.

@en

European consensus table on the use of botulinum toxin type A in adult spasticity.

@nl

prefLabel

European consensus table on the use of botulinum toxin type A in adult spasticity.

@ast

European consensus table on the use of botulinum toxin type A in adult spasticity.

@en

European consensus table on the use of botulinum toxin type A in adult spasticity.

@nl

P1433

Q34604258-6AE91782-2A41-4BFA-AAFE-3CCAD672335D

P1476

Q34604258-0B148C72-EB5A-470E-852C-7674BC0C25C4

P2093

Q34604258-2312E61D-EF48-42E2-8811-AB08C9135EDA

Q34604258-28927F4B-581E-413A-8637-79C0CC81CAB3

Q34604258-2B5B95A5-BA0E-4BD5-BBA2-5C70E841EE7D

Q34604258-2F1F174E-431F-41CA-908A-1147F1F2D81C

Q34604258-36FB405F-67B9-45EB-8679-2C05F9976A5C

Q34604258-449D9D0E-133A-4D1A-8083-263A0FE15077

Q34604258-49A5F1C1-4684-4EDC-84AB-DAD829CAABEE

Q34604258-5C0B9A9E-B204-4255-BE1D-A11F5DFA237A

Q34604258-61B69AB8-59AE-4449-808A-7F5186BC6DF9

Q34604258-6A2D98BD-1BA3-45AE-9994-DD635283877C

P304

Q34604258-9E578FCF-6D63-47ED-A2F1-F055593B307F

P31

Q34604258-9BCB9FC3-FA3D-4D6C-8D11-294EFE8FBCA0

P356

Q34604258-25D99C81-6908-4B08-9231-CABD5560D349

P433

Q34604258-169E0FF2-6553-4D87-BB9A-E4781AFDEB71

P478

Q34604258-DC6C3706-7CB4-43F1-A715-61B9CD6C2F6D

P50

Q34604258-C2E62B1A-E000-48A2-85B8-2697EC151B4F

Q34604258-EBF8397F-C5C9-4461-8FFD-1C0718028ED9

Q34604258-EC9A59D0-4267-4BA5-91BA-AF83BFD95871

P577

Q34604258-E3A2FB8E-0EF1-4EE9-9BA0-66DA1CBA4333

P5875

Q34604258-7E884965-0C8B-4B31-92D6-F4EFE178A7B6

P698

Q34604258-3D4F0480-09F6-4608-89EA-31ABADE065EF

P356

P1433

Journal of Rehabilitation Medicine

P1476

European consensus table on the use of botulinum toxin type A in adult spasticity.

@en

P2093

Alexander C H Geurts

http://www.w3.org/2001/XMLSchema#string

Anthony B Ward

http://www.w3.org/2001/XMLSchema#string

Christian Kätterer

http://www.w3.org/2001/XMLSchema#string

Djamel Bensmail

http://www.w3.org/2001/XMLSchema#string

Francisco J Juan

http://www.w3.org/2001/XMLSchema#string

Jaroslaw Slawek

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Gracies

http://www.w3.org/2001/XMLSchema#string

Jörg Wissel

http://www.w3.org/2001/XMLSchema#string

Konstantina Petropoulou

http://www.w3.org/2001/XMLSchema#string

Marc Rousseaux

http://www.w3.org/2001/XMLSchema#string

P304

13-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2340/16501977-0303

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Lejeune

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23983876

http://www.w3.org/2001/XMLSchema#string

P698

19197564

http://www.w3.org/2001/XMLSchema#string